Bio News
Researchers at Crete Medical designed a three-component electrospun scaffold whose pores expand from 80.4 micrometers to 153.6 micrometers in 7 days. The scaffold widened the space available for fibroblast migration as three materials with different degradation rates maintained the structure in stages. The U.S. Food and Drug Administration (FDA) granted 510(k) clearance to a product incorporating this structure.
BIOBOOK TEAM
biobookmedia@biobook.co.krParagon Spin-Off Velaris Goes Public Through Reverse Merger With Alaunos
Syndax halts development of Niktimvo for pulmonary fibrosis; shares plunge 17%
BioNTech’s mRNA Cancer Vaccine Misses Primary Endpoint for Progression-Free Survival in Phase 3 Trial
Roche Signs $1.6 Billion Deal With China’s Rona for ALK7 Obesity Drug
Formycon and Zydus’ Keytruda Biosimilar Is First to Be Accepted for FDA Review
Pfizer Signs $500 Million Protein Degrader Deal With Enodia
